syndrom
coronaviru
becom
global
threat
public
health
aim
construct
effici
screen
pattern
comprehens
evalu
perform
rtpcr
chest
ct
diagnos
record
includ
demograph
rtpcr
ct
confirm
case
exclus
case
collect
diagnost
accuraci
pharyng
swab
rtpcr
ct
combin
second
pharyng
swab
rtpcr
ct
evalu
individu
besid
stool
rtpcr
result
plot
time
explor
valu
stool
rtpcr
find
combin
rtpcr
ct
higher
sensit
rtpcr
alon
ct
alon
combin
two
rtpcr
test
good
agreement
rtpcr
ct
kappavalu
case
inconsist
result
mild
infect
show
posit
rtpcr
patient
least
one
posit
stool
cours
two
case
posit
stool
earlier
pharyng
swab
importantli
one
patient
consecut
posit
stool
neg
pharyng
swab
interpret
combin
rtpcr
ct
highest
sensit
optim
pattern
screen
rtpcr
superior
ct
diagnos
mild
infect
stool
rtpcr
consid
item
improv
discoveri
rate
hospit
discharg
studi
shed
light
optim
scheme
screen
monitor
infect
medrxiv
preprint
persontoperson
transmiss
hospit
famili
set
februari
laboratoryconfirm
death
case
document
china
countri
worldwid
includ
usa
german
japan
south
korea
mortal
rate
around
recent
declar
public
health
emerg
intern
concern
thu
diagnost
test
specif
infect
urgent
need
confirm
suspect
case
screen
patient
conduct
viru
surveil
identif
pathogen
mainli
includ
viru
isol
viral
nucleic
acid
detect
accord
tradit
koch
postul
viru
isol
gold
standard
viru
diagnosi
laboratori
thu
base
possess
strong
capabl
infect
human
cdc
recommend
clinic
virolog
laboratori
attempt
viral
isol
specimen
collect
patient
investig
newli
discov
viru
spectrum
avail
diagnost
tool
tight
earli
stage
detect
human
clinic
specimen
nextgener
sequenc
cell
cultur
electron
microscopi
develop
accur
rapid
method
identifi
emerg
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
respiratori
pathogen
still
need
full
genom
sequenc
exclud
poli
tail
genbank
access
number
releas
quickli
januari
ident
sarscov
bat
sarslik
coronaviru
slcov
basi
analysi
complet
genom
obtain
studi
sever
laboratori
develop
molecular
detect
tool
base
target
rnadepend
rna
polymeras
rdrp
gene
n
e
region
viral
spike
gene
rapid
identif
novel
coronaviru
attribut
recent
advanc
detect
includ
rtpcr
realtim
revers
transcript
pcr
rrtpcr
revers
transcript
loopmedi
isotherm
amplif
rtlamp
microarraybas
assay
present
rtpcr
wide
use
detect
techniqu
sever
market
nucleic
acid
detect
kit
use
clinic
current
standard
refer
pneumonia
diagnosi
posit
result
nucleic
acid
detect
assay
upper
lower
respiratori
tract
specimen
blood
respiratori
tract
specimen
includ
nasal
pharyng
swab
specimen
sputum
bronchoalveolar
lavag
fluid
patient
confirm
pneumonia
continu
neg
rtpcr
result
nasopharyng
throat
swab
specimen
discharg
hospit
howev
scholar
around
china
indic
case
continu
neg
rtpcr
result
nasopharyng
throat
swab
specimen
final
laboratoryconfirm
current
sever
report
report
posit
rtpcr
result
stool
patient
base
infect
patient
potenti
shed
respiratori
fecalor
rout
valu
rtpcr
result
stool
earli
diagnosi
monitor
infect
studi
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
retriev
data
record
microsoft
excel
analyz
continu
variabl
express
median
rang
deviat
independ
sampl
ttest
onesampl
ttest
util
compar
signific
differ
among
continu
data
statist
analysi
agreement
perform
use
mcnemar
chisquar
test
regard
statist
signific
valu
less
use
r
version
analys
result
patient
involv
studi
sum
includ
local
resid
wuhan
recent
travel
wuhan
contact
peopl
wuhan
elig
epidemiolog
criteria
suspect
case
receiv
medic
isol
examin
diagnosi
among
patient
male
throughout
whole
spectrum
age
year
group
gener
popul
studi
patient
age
year
tabl
diseas
sever
patient
mild
patient
sever
earli
stage
covid
outbreak
rtpcr
ct
scan
main
measur
screen
infect
henc
collect
result
two
method
period
jan
th
feb
th
total
specimen
patient
detect
rtpcr
includ
pharyng
stool
patient
admiss
receiv
least
one
rtpcr
detect
pharyng
swab
patient
subject
second
rtpcr
test
pharyng
swab
stool
detect
rtpcr
account
patient
among
patient
patient
subject
ct
scan
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
rtpcr
ct
evalu
futur
case
subject
first
rtpcr
second
rtpcr
pharyng
subject
ct
scan
analyz
perform
index
shown
result
show
sensit
rtpcr
parallel
ct
scan
highest
higher
parallel
second
nucleic
acid
specif
two
nucleic
acid
detect
significantli
higher
combin
nucleic
acid
ct
suggest
nucleic
acid
parallel
ct
appropri
screen
infect
two
nucleic
acid
test
exclus
diagnosi
mayb
suitabl
report
aliv
viru
surviv
stool
patient
accord
data
patient
identifi
combin
rtpcr
pharyng
swab
ct
scan
sinc
rtpcr
test
stool
effici
assist
examin
studi
case
subject
stool
nucleotid
detect
therefor
rtpcr
result
case
stool
nucleotid
detect
plot
along
time
axi
demonstr
case
least
one
posit
result
discoveri
rate
stool
present
earlier
posit
throat
swab
two
case
patient
moreov
pharyng
swab
patient
alway
neg
end
studi
patient
remain
posit
result
stool
two
consecut
neg
result
pharyng
swab
patient
hospit
importantli
discharg
patient
two
case
stool
neg
later
pharyng
swab
patient
data
suggest
detect
fecal
nucleic
acid
could
employ
improv
discoveri
rate
might
develop
indic
monitor
deisol
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
discuss
novel
betacoronaviru
major
caus
symptomat
respiratori
tract
infect
age
group
worldwid
time
accur
diagnosi
viru
enabl
appropri
treatment
infect
rtpcr
wide
deploy
diagnost
virolog
case
public
health
emerg
profici
diagnost
laboratori
reli
robust
technolog
establish
new
diagnost
test
within
routin
servic
preformul
assay
becom
avail
studi
sensit
rtpcr
greater
report
vs
first
assay
reason
high
sensit
seri
may
includ
first
sampl
hospit
patient
nasopharyng
oropharyng
swab
collect
test
separ
studi
detect
specimen
patient
pharyng
nasal
swab
combin
compar
pharyng
nasal
swab
indic
higher
sensit
initi
screen
show
strategi
detect
viral
rna
pharyng
nasal
swab
use
diagnosi
perfect
also
found
viru
present
sever
stool
swab
patient
pharyng
nasal
swab
detect
neg
base
infect
patient
potenti
shed
pathogen
respiratori
fecalor
rout
appli
test
oral
stool
swab
could
greatli
improv
detect
posit
rate
among
laboratoryconfirm
case
still
case
rtpcr
result
test
neg
first
assay
fals
neg
caus
poor
sampl
qualiti
respiratori
tract
sampl
collect
oropharynx
collect
earli
late
progress
diseas
earli
stage
number
virus
bodi
enough
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
detect
sampl
properli
store
transport
process
coronaviru
rna
viru
prone
death
degrad
process
collect
sampl
transport
laboratori
test
take
long
time
nucleic
acid
easi
degrad
easi
detect
posit
last
technic
factor
includ
viru
mutat
pcr
inhibit
studi
sensit
rtpcr
higher
chest
ct
vs
respect
reason
rel
lower
effici
chest
ct
may
includ
major
patient
mild
earli
detect
featur
typic
featur
chest
ct
studi
divid
three
group
patient
one
group
posit
group
neg
result
support
rtpcr
combin
chest
ct
first
screen
patient
clinic
epidemiolog
featur
earli
decemb
first
pneumonia
case
unknown
origin
identifi
wuhan
citi
hubei
provinc
china
jan
novel
coronaviru
discov
use
highthroughput
sequenc
throat
swab
sampl
patient
current
name
previous
known
februari
ictv
initi
defin
case
epidemiolog
link
human
seafood
market
wuhan
although
later
found
without
exposur
market
histori
wuhan
contact
patient
pneumonia
confirm
current
epidemiolog
data
indic
fever
cough
dyspnea
common
symptom
patient
pneumonia
manifest
similar
two
diseas
caus
coronavirus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
ct
import
method
diagnosi
lung
lesion
radiolog
chang
lung
patient
character
zhong
et
al
report
patient
underw
ct
admiss
around
manifest
abnorm
ct
imag
featur
usual
exhibit
typic
radiolog
find
groundglass
opac
bilater
patchi
shadow
base
diagnosi
treatment
guidelin
new
coronaviru
pneumonia
fifth
edit
china
ct
scan
use
clinic
diagnost
criteria
pneumonia
strictli
limit
hubei
provinc
howev
specif
chest
ct
rel
could
distinguish
infect
pathogen
well
caus
extens
outbreak
cold
winter
season
mani
pathogen
caus
pneumonia
also
becom
preval
even
includ
mani
viral
agent
infecti
diseas
share
common
characterist
sign
symptom
laboratori
find
therefor
difficult
differenti
suffer
pneumonia
patient
pure
depend
manifest
routin
examin
therefor
precis
screen
scheme
urgent
employ
high
sensit
test
pivot
avoid
secondari
transmiss
miss
diagnos
case
meanwhil
posit
predict
valu
also
count
number
fals
posit
would
bring
occup
cost
healthcar
resourc
also
increas
infect
risk
suspect
case
isol
hospit
studi
perform
retrospect
studi
case
compar
efficaci
rtpcr
ct
diagnost
approach
diagnosi
provid
evid
futur
strateg
diagnosi
region
outsid
hubei
provinc
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
retrospect
singl
center
studi
recruit
patient
jan
feb
fifth
affili
hospit
sun
yatsen
univers
zhuhai
china
design
infecti
hospit
period
rtpcr
chest
ct
perform
consecut
patient
includ
local
resid
wuhan
outsid
wuhan
recent
travel
wuhan
contact
peopl
fever
respiratori
symptom
wuhan
fever
acut
respiratori
symptom
unknown
caus
patient
recruit
feb
suspect
diagnosi
therefor
exclud
studi
patient
diagnos
patient
exclus
accord
interim
guidanc
enrol
studi
perform
first
rtpcr
detect
pharyng
swab
chest
ct
evalu
sensit
specif
youden
index
et
al
perform
combin
second
rtpcr
chest
ct
also
calcul
agreement
two
method
analyz
use
mcnemar
chisquar
test
final
rtpcr
result
pharyng
stool
plot
time
explor
valu
stool
nucleic
detect
fig
sever
pneumonia
defin
base
intern
guidelin
communityacquir
pneumonia
laboratori
ct
characterist
data
obtain
standard
data
collect
form
electron
medic
record
studi
approv
fifth
affili
hospit
sun
yatsen
univers
ethic
committe
written
inform
consent
obtain
patient
involv
enrol
data
collect
retrospect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
laboratori
test
assay
base
previou
recommend
upper
respiratori
tract
specimen
pharyng
nasal
swab
stool
obtain
case
ensur
specimen
collect
name
gender
age
patient
well
serial
number
abnorm
specimen
note
rna
extract
test
realtim
rtpcr
specif
primer
probe
accord
instruct
kit
realtim
rtpcr
carri
biosafeti
level
facil
clinic
laboratori
two
target
rdrp
e
n
test
posit
specif
rtpcr
patient
would
consid
laboratoryconfirm
neg
ct
valu
ct
posit
ct
valu
ct
valu
indetermin
requir
confirm
repeat
repeat
ct
valu
sampl
posit
otherwis
neg
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
look
case
data
retrospect
found
patient
without
ct
scan
admit
hospit
complain
epidemiolog
contact
although
eventu
diagnos
mild
symptom
upper
respiratori
tract
infect
admiss
cours
infect
ct
scan
perform
begin
outbreak
rtpcr
pharyng
ct
scan
main
besid
also
analyz
agreement
two
method
case
uncertain
ct
result
involv
statist
analysi
due
statist
limit
shown
statist
signific
two
method
p
moreov
statist
differ
diagnosi
patient
p
patient
agreement
good
fair
agreement
kappa
valu
adjust
agreement
patient
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
given
time
receiv
detect
caus
influenc
sensit
time
differ
rtpcr
pharyng
ct
scan
compar
averag
time
nucleic
acid
screen
earlier
ct
scan
statist
tabl
notabl
method
acquir
sensit
less
screen
infect
ideal
enough
diagnosi
infecti
diseas
sever
consequ
develop
appropri
detect
scheme
perform
combin
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
day
differ
first
rtpcr
detect
ct
scan
perform
statist
analysi
onesampl
test
use
test
statist
signific
mean
group
zero
p
level
independ
sampl
test
use
test
statist
signific
day
differ
group
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
